The University of Michigan's Arul Chinnaiyan has led a study that identified several biomarkers for advanced stage prostate cancer, says an article at BBC. The researchers examined 1,126 molecules in a total of 262 samples of tissue, blood, or urine, and found one metabolite, sarcosine, to be a better predictor of late-stage disease than PSA. While a simple urine test is still around five years away, they say, it's promising work.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.